Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIq-ai Ltd Share News (IQAI)

Share Price Information for Iq-ai Ltd (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.60
Bid: 1.50
Ask: 1.70
Change: -0.10 (-5.88%)
Spread: 0.20 (13.333%)
Open: 1.65
High: 1.65
Low: 1.60
Prev. Close: 1.70
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Chamberlin Gets GBP200,000 Funding From IQ-AI CEO Brown

Fri, 19th Feb 2021 17:39

Chamberlin PLC - castings and engineering firm - Receives GBP200,000 of new funding from real estate investor and IQ-AI Ltd Chief Executive Trevor Brown. Brown, who is also CEO of Braveheart Investment Group PLC has been issued with GBP200,000 notes as the funding was advanced through an unsecured convertible loan note instrument. Subject to shareholder approval, these notes will convert automatically into 3.3 million new shares at 6 pence each, a 14% discount to the January 3 closing middle market price before suspension. The shares will represent an approximately 29.5% stake in Chamberlin's enlarged share capital.

Upon conversion, conditional on the passing of resolutions at its March 8 general meeting, Chamberlin has agreed to appoint Brown as a non-executive director, where he "has agreed to explore with the board all potential options of further funding to help stabilise the short-to-medium term working capital requirements of the company."

Following this transaction, and further fundraising, possibly including additional equity fundraising, Chamberlin will be in a position to publish its annual accounts for its financial year ended March 2020 on a going concern basis as well as its interim results for the six months ended September 30. This should, in turn, result in its share suspension being lifted.

The note conversion is conditional on shareholder approval for re-organising Chamberlin's share capital and the granting of necessary share allotment authorities to directors. This is because authorities granted July 2019 has expired, meaning not only the conversion but also any future equity fundraising are dependent on shareholder approval.

Chamberlin notes that if it cannot obtain additional funds it "will be unable to continue trading as a going concern" and that if shareholders do not pass the needed resolution then it "is expected to be unable to comply with one or more financial covenants that are in place under the terms of its existing facilities with its lending banks."

"If the company is unable to reach agreement on alternative arrangements with its lending banks and other creditors (including HM Revenue & Customs), then this could lead to enforcement action over all or part of the group's assets including executing a disposal of such assets. In the event that the resolutions are not passed, the directors would likely seek to place the company into some form of insolvency proceeding, or a creditor may take action to enforce or initiate an insolvency proceeding. Any such proceeding would be likely to result in little or no value for shareholders. Accordingly it is important that Shareholders vote in favour of all of the resolutions so that the conversion may proceed and all funding options are available to the board," says Chamberlin.

Current stock price: 7.00 pence

By Anna Farley; annafarley@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
4 Sep 2019 11:43

IQ-AI Unit Imaging Biometrics Receives USD2.8 Million Grant

(Alliance News) - Medical devices firm IQ-AI Ltd said Wednesday its subsidiary Imaging Biometrics, in conjunction with the Medical College of Wisconsin, has received a five-year grant award worth

Read more
9 Jul 2019 12:22

IQ-AI Notes New Studies Showing Danger Of Gadolinium Contrast Agents

(Alliance News) - IQ-AI Ltd on Tuesday said there have been more studies showing possible dangers from the gadolinium-based contrast agents used for MRIs, which is good news for its own a of and a

Read more
26 Jun 2019 14:08

Medical Software Company IQ-AI Raises GBP250,000 Via Share Placing

(Alliance News) - IQ-AI Ltd on Wednesday said it has raised GBP250,000 through a share placing.The medical software company said it issued 7.1 million shares at a price of 3.5 pence shares

Read more
26 Jun 2019 10:49

IQ-AI raises ?0.25m to accelerate development of imaging biometrics projects

(Sharecast News) - IQ-AI announced on Wednesday that, following "strong demand" from existing and new shareholders, it has raised £0.25m through the placing of 7,142,857 new ordinary shares at a price of 3.5p each.

Read more
12 Jun 2019 16:20

IQ-AI Inks Business Development Pact With CorTechs Labs

(Alliance News) - Medical software services provider IQ-AI Ltd said Wednesday it has entered into an agreement to expand its product offering in the US and other international markets.The a

Read more
30 Apr 2019 16:06

IQ-AI Shares Jump As It Expects Sales To Double In 2019

LONDON (Alliance News) - Medical software firm IQ-AI Ltd on Tuesday issued an upbeat outlook for the year ahead as it recorded revenue in 2018, though its annual loss did widen.Shares in up

Read more
11 Mar 2019 09:44

IQ-AI Raises Cash From Chair, Subsidiary Head Via Loan Notes (ALLISS)

LONDON (Alliance News) - IQ-AI Ltd on Monday said it has issued GBP268,500 worth of 6% unsecured convertible loan notes 2024 to provide it with some working capital.Shares in the company, a

Read more
8 Feb 2019 11:56

IQ-AI Shares Plunge On Delay Of StoneChecker Software Approval In US

LONDON (Alliance News) - Shares in IQ-AI Ltd were trading lower on Friday as the company said the US approval of its StoneChecker software was delayed due to the government shutdown.The as

Read more
11 Dec 2018 10:08

IQ-AI subsidiary sees tech installed at important tumour centre

(Sharecast News) - IQ-AI subsidiary Imaging Biometrics (IB) announced on Tuesday that Barrow Neurological Institute: Dignity Health, St. Joseph's Hospital and Medical Center (BNI) has installed a new 'IB Rad Tech' software platform, to help assess treatment response for patients with brain tumours.

Read more
28 Nov 2018 12:16

IQ-AI Appoints First South East Asian Imaging Biometrics Distributor

LONDON (Alliance News) - IQ-AI Ltd on Wednesday said Korea Motion ISG has been appointed as the first South East Asian distributor of its Imaging Biometrics LLC products.IQ-AI subsidiary to

Read more
28 Nov 2018 12:05

IQ-AI's Imaging Biometrics signs Korea distribution deal

(Sharecast News) - IQ-AI announced on Wednesday that its subsidiary Imaging Biometrics has appointed Korea Motion as its first distributor in South East Asia.

Read more
22 Oct 2018 11:41

IQ-AI Files Patent For Gadolinium-Free MRI Brain Scan Technology

LONDON (Alliance News) - IQ-AI Ltd, formerly known as Flying Brands Ltd, said Monday it has filed a patent for a type of magnetic resonance imaging that does not use gadolinium contrast in IQ-AI a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.